Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about FDA
Recent news which mentions FDA
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know
October 02, 2022
Tickers
ALNY
AMLX
AZN
BLUE
Tags
IBB
Top Stories
MRK
From
Benzinga
Regeneron-Sanofi's Flagship Dupixent Becomes First FDA-Approved Treatment For Prurigo Nodularis
September 29, 2022
Tickers
REGN
SNY
Tags
Large Cap
FDA
Biotech
From
Benzinga
FDA Finally Advances Cannabis Research & Regulations: Hires Ex-NY Cannabis Policy Regulator
September 28, 2022
Tags
Norman Birenbaum
Markets
Janet Woodcock
From
Benzinga
Pharming's Leniolisib Goes Under Priority FDA Review For Rare Immune System Disorder
September 28, 2022
Tickers
PHAR
Tags
Small Cap
General
News
From
Benzinga
Thermo Fisher's Oncomine Dx Test Is First FDA Approved NGS-Based Companion Diagnostic To Detect Thyroid Cancers
September 28, 2022
Tickers
LLY
TMO
Tags
General
News
Market News
From
Benzinga
FDA Approves First Branded Ocular Anesthetic In Almost 14 Years
September 28, 2022
Tickers
HROW
Tags
Health Care
Market News
General
From
Benzinga
Why Biogen Stock Is Up 40% Today
September 28, 2022
Tickers
BIIB
ESALY
Tags
Trading Ideas
General
alzheimer's
From
Benzinga
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
September 28, 2022
Tickers
BIIB
ESALY
Tags
lecanemab
Benzinga
Biotech
From
Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
September 27, 2022
Tickers
A
ABT
BDX
BRKR
Tags
EXAS
QGEN
LHDX
From
Benzinga
Why Are Bellerophon Shares Jumping Today?
September 27, 2022
Tickers
BLPH
Tags
Trading Ideas
Briefs
News
From
Benzinga
FDA Slaps Clinical Hold On Avidity's Early-Stage Myotonic Dystrophy Trial
September 27, 2022
Tickers
RNA
Tags
Market News
RNA
Movers
From
Benzinga
As Moderna Grapples With Supply Shortage, FDA Gives Nod To Additional Lots of COVID-19 Booster
September 27, 2022
Tickers
BNTX
CTLT
CVS
MRNA
Tags
Market News
Media
Health Care
From
Benzinga
FDA Clears MoonLake's Nanobody Study For Arthritis Patients
September 26, 2022
Tickers
MLTX
Tags
Benzinga
FDA
Biotech
From
Benzinga
Pulse Biosciences Lead Therapeutic System Scores FDA Approval For Sebaceous Hyperplasia
September 26, 2022
Tickers
PLSE
Tags
Health Care
Movers
Market News
From
Benzinga
Atea Pharma's Investigational Dengue Treatment Fast Tracked In US
September 26, 2022
Tickers
AVIR
Tags
Market News
Health Care
General
From
Benzinga
< Previous
1
2
...
26
27
28
29
30
31
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today